Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader May 2, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by globenewswire. Read more Source: https://www.globenewswire.com/news-release/2026/05/01/3285840/33090/en/Axsome-Therapeutics-Hosts-AUVELITY-FDA-Approval-Investor-Event-Featuring-Expert-Thought-Leader.html
